Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Relationship between medication adherence and treatment outcomes: the COMBINE study.

Zweben A, Pettinati HM, Weiss RD, Youngblood M, Cox CE, Mattson ME, Gorroochurn P, Ciraulo D.

Alcohol Clin Exp Res. 2008 Sep;32(9):1661-9. doi: 10.1111/j.1530-0277.2008.00743.x. Epub 2008 Jul 9.

2.

Temporal patterns of adherence to medications and behavioral treatment and their relationship to patient characteristics and treatment response.

Gueorguieva R, Wu R, Krystal JH, Donovan D, O'Malley SS.

Addict Behav. 2013 May;38(5):2119-27. doi: 10.1016/j.addbeh.2013.01.024. Epub 2013 Feb 4.

3.

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A; COMBINE Study Research Group.

JAMA. 2006 May 3;295(17):2003-17.

PMID:
16670409
4.

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Greenfield SF, Pettinati HM, O'Malley S, Randall PK, Randall CL.

Alcohol Clin Exp Res. 2010 Oct;34(10):1803-12. doi: 10.1111/j.1530-0277.2010.01267.x. Epub 2010 Jul 20.

5.

Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes.

Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Jan;69(1):5-13.

PMID:
18080059
6.

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Doggrell SA.

Expert Opin Pharmacother. 2006 Oct;7(15):2169-73.

PMID:
17020440
7.
8.

Does family history of alcoholism moderate naltrexone's effects on alcohol use?

Capone C, Kahler CW, Swift RM, O'Malley SS.

J Stud Alcohol Drugs. 2011 Jan;72(1):135-40.

PMID:
21138720
9.

Cravings as a mediator and moderator of drinking outcomes in the COMBINE study.

Subbaraman MS, Lendle S, van der Laan M, Kaskutas LA, Ahern J.

Addiction. 2013 Oct;108(10):1737-44. doi: 10.1111/add.12238. Epub 2013 Jun 4.

10.

Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study.

DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ.

Drug Alcohol Depend. 2013 Sep 1;132(1-2):244-50. doi: 10.1016/j.drugalcdep.2013.02.013. Epub 2013 Apr 6.

11.
12.

Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.

Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R; COMBINE Study Research Group.

J Stud Alcohol Drugs. 2008 Nov;69(6):878-84.

13.

Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.

Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF; PREDICT Study Team.

Addict Biol. 2013 Nov;18(6):937-46. doi: 10.1111/adb.12012. Epub 2012 Dec 12.

PMID:
23231446
14.

Self-efficacy change as a mediator of associations between therapeutic bond and one-year outcomes in treatments for alcohol dependence.

Hartzler B, Witkiewitz K, Villarroel N, Donovan D.

Psychol Addict Behav. 2011 Jun;25(2):269-78. doi: 10.1037/a0022869.

15.
16.

Baseline trajectories of heavy drinking and their effects on postrandomization drinking in the COMBINE Study: empirically derived predictors of drinking outcomes during treatment.

Gueorguieva R, Wu R, Donovan D, Rounsaville BJ, Couper D, Krystal JH, O'Malley SS.

Alcohol. 2012 Mar;46(2):121-31. doi: 10.1016/j.alcohol.2011.08.008. Epub 2011 Sep 17.

17.

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study.

Ray LA, Oslin DW.

Drug Alcohol Depend. 2009 Dec 1;105(3):256-8. doi: 10.1016/j.drugalcdep.2009.07.006. Epub 2009 Aug 29.

18.

Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients.

Zarkin GA, Bray JW, Aldridge A, Mitra D, Mills MJ, Couper DJ, Cisler RA; COMBINE Cost-Effectiveness Research Group.

Arch Gen Psychiatry. 2008 Oct;65(10):1214-21. doi: 10.1001/archpsyc.65.10.1214.

19.

Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials.

Falk D, Wang XQ, Liu L, Fertig J, Mattson M, Ryan M, Johnson B, Stout R, Litten RZ.

Alcohol Clin Exp Res. 2010 Dec;34(12):2022-34. doi: 10.1111/j.1530-0277.2010.01290.x.

PMID:
20659066
20.

Simultaneous modeling of the impact of treatments on alcohol consumption and quality of life in the COMBINE study: a coupled hidden Markov analysis.

Prisciandaro JJ, DeSantis SM, Bandyopadhyay D.

Alcohol Clin Exp Res. 2012 Dec;36(12):2141-9. doi: 10.1111/j.1530-0277.2012.01823.x. Epub 2012 May 2.

Items per page

Supplemental Content

Write to the Help Desk